Marguerite Schabell
Family Medicine · Ft. Wright, KYNPI 1043237639
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 31.6% of the total. Reporting peaked in 2019 at $479 and has fallen 96.6% since, to $16 in 2025.
Across 65 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$347
- Amgen$173
- Pfizer$74
- Boehringer Ingelheim$68
- Novartis$58
- Takeda Pharmaceuticals U.S.A., Inc.$49
- plus $331 from 16 others
What the payments were for
- Food & beverage$1,099100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $347 |
| Amgen | 8 | $173 |
| Pfizer | 5 | $74 |
| Boehringer Ingelheim | 4 | $68 |
| Novartis | 4 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $49 |
| Cordis US CORP. | 2 | $41 |
| Johnson & Johnson | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $29 |
| Astellas Pharma US Inc | 2 | $28 |
| AstraZeneca | 2 | $26 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Abbott | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Novo Nordisk | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Boston Scientific | 1 | $11 |
| GSK | 1 | $11 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$1,099 in reported general payments places this provider in the 55th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 14 | $211 |
| Atorvastatin Calcium | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ft. Wright
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
- Derek JonesAshland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.